From: microRNA-21 expressions impact on liver fibrosis in biliary atresia patients
Characteristics | N (%); mean ± SD |
---|---|
Sex | |
Male | 7 (43.8) |
Female | 9 (56.2) |
BA type | |
1 | 0 |
2A | 5 (31.2) |
2B | 4 (25) |
3 | 7 (43.8) |
Pre-operative laboratory findings | |
Total bilirubin (mg/dL) | 10.7 ± 4.2 |
Direct bilirubin (mg/dL) | 8.1 ± 3.2 |
Alanine aminotransferase (ALT) (U/L) | 148.3 ± 72.6 |
Aspartate aminotransferase (AST) (U/L) | 282.3 ± 222.3 |
Alkaline phosphatase (ALP) (U/L) | 508.7 ± 181.3 |
Gamma glutamyl transferase (GGT) (U/L) | 471.2 ± 324.6 |
Age at Kasai procedure (days) | 106.8 ± 54.2 |
Post-operative laboratory findings | |
Total bilirubin (mg/dL) | 9.2 ± 5.0 |
Direct bilirubin (mg/dL) | 7.0 ± 3.3 |
Alanine aminotransferase (ALT) (U/L) | 170.0 ± 148.6 |
Aspartate aminotransferase (AST) (U/L) | 238.2 ± 363.0 |
Alkaline phosphatase (ALP) (U/L) | 243.8 ± 120.6 |
Gamma glutamyl transferase (GGT) (U/L) | 492.7 ± 516.8 |
Post-operative clinical findings | |
Ascites | 7 (43.8) |
Cholangitis | 6 (37.5) |
Sepsis | 10 (62.5) |
Portal hypertension | 6 (37.5) |
Esophageal varices | 5 (31.3) |
Histopathological findings of liver biopsy | |
Cirrhosis | 4 (25) |
Non-cirrhosis | 12 (75) |
Survival rate | 7 (43.8) |